Stephens & Co. Reiterates Equal-Weight on Oscar Health, Maintains $34 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.2%

Neg 0% Neu 90.2% Pos 0%

Stephens & Co. analyst Raj Kumar reiterates Oscar Health (NYSE:OSCR) with a Equal-Weight and maintains $34 price target.